by | Dec 18, 2019 | Murphy, Kenneth
— Researchers first identified and then used CRISPR to delete an enhancer located at +32 kb of the Irf8 transcriptional start site in mice. Knocking out this enhancer revealed that interferon regulatory factor 8 (IRF8) is required for the development of classical type 1 dendritic cells (cDC1s) but not…
by | Nov 27, 2019 | Murphy, Kenneth
— Irf8 Delta32 mice have a CRISPR targetted deletion in the enhancer of the mouse Irf8 gene located at +32 kilobases from the Irf8 gene promoter. This deletion removes the binding site for the Jun/Batf3/Irf8 complex and results in a complete and permanent elimination of the development of the cDC1 lin…
by | Nov 13, 2019 | Durai, Vivek, Murphy, Kenneth, Murphy, Theresa
— Xcr1 IRES mCherry-hCre Mouse Strain
This genetically modified mouse strain expresses the fluorescent marker mCherry and a human codon optimzed Cre in the same transcript as the chemokine receptor XCR1. XCR1 is specifically expressed in cDC1s, allowing specific deletion of genes in and the fluoresce…
by | Oct 22, 2019 | Murphy, Kenneth, Murphy, Theresa
— Notes: Btla-/- knockout mouse with a 129S/SvEv background. B6.129.Btla tm1kmm/J Mouse.
by | Oct 22, 2019 | Diamond, Michael, Murphy, Kenneth, Murphy, Theresa, Schreiber, Robert, Unanue, Emil
— Notes: Batf3-/- knockout mouse with a 129SvEv background.
by | Mar 10, 2018 | Albring, Jorn, Murphy, Kenneth, Sandau, Michelle
— Background: Allogeneic hematopoietic stem-cell transplantation (aHSCT) from a healthy donor can cure a variety of blood cell disorders including leukemia, multiple myeloma, and some types of lymphoma. This has resulted in an increasing number of transplants, surpassing 8,000 a year in the US alone. …